Aleafia Health (DB:ARAH) - Hisse Senedi Fiyatı, Haberler ve Analizler

ARAH Stoklara Genel Bakış

Aleafia Health Inc., together with its subsidiaries, operates as cannabis health and wellness company in Canada, Europe, and Australia. Daha fazla detay

ARAH temel anali̇z
Kar Tanesi Skoru
Değerleme	2/6
Gelecekteki Büyüme	0/6
Geçmiş Performans	0/6
Finansal Sağlık	0/6
Temettüler	0/6

Risk Analizi

Kazançlar son 5 yılda yılda 30% oranında azaldı

Anlamlı bir piyasa değeri yok ( €8M )

Negatif hissedar öz sermayesi

Hisse senetleri oldukça likit değildir

+ 1 daha fazla risk

Aleafia Health Inc. Rakipler

Biofrontera

XTRA:B8FK

€16.1m

SynBiotic

DUSE:SBX

€27.9m

Cantourage Group

XTRA:HIGH

€57.6m

Redx Pharma

DB:0RX

€65.0m

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Aleafia Health
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	CA$0.015
52 Haftanın En Yüksek Seviyesi	CA$0.079
52 Haftanın En Düşük Seviyesi	CA$0.0005
Beta	1.73
11 Aylık Değişim	0%
3 Aylık Değişim	3,000.00%
1 Yıllık Değişim	-50.79%
33 Yıllık Değişim	-94.60%
5 Yıllık Değişim	-97.67%
Halka arzdan bu yana değişim	-96.70%

Son Haberler & Güncellemeler

Recent updates

Hissedar Getirileri

	ARAH	DE Pharmaceuticals	DE Pazar
7D	0%	1.6%	1.1%
1Y	-50.8%	-19.0%	7.2%

Getiri vs. Endüstri: ARAH geçen yıl % -19 oranında getiri sağlayan German Pharmaceuticals sektörünün gerisinde kaldı.

Getiri vs Piyasa: ARAH geçen yıl % 7.2 oranında getiri sağlayan German Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is ARAH's price volatile compared to industry and market?
ARAH volatility
ARAH Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	7.0%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	10.9%
10% least volatile stocks in DE Market	2.4%

İstikrarlı Hisse Senedi Fiyatı: ARAH hisse senedi fiyatı son 3 aydır dalgalı bir seyir izliyor.

Zaman İçindeki Volatilite: ARAH 'un son bir yıldaki oynaklık değişimini belirlemek için Yetersiz veri.

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
n/a	158	Tricia Symmes	www.aleafiahealth.com

Aleafia Health Inc. Temel Bilgiler Özeti

Aleafia Health'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
ARAH temel i̇stati̇sti̇kler
Piyasa değeri	€5.48m
Kazançlar(TTM)	-€23.53m
Gelir(TTM)	€29.13m

0.2x

P/S Oranı

-0.2x

F/K Oranı

ARAH aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
ARAH gelir tablosu (TTM)
Gelir	CA$42.85m
Gelir Maliyeti	CA$36.85m
Brüt Kâr	CA$6.00m
Diğer Giderler	CA$40.61m
Kazançlar	-CA$34.61m

Son Raporlanan Kazançlar

Mar 31, 2023

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)	-0.086
Brüt Marj	14.00%
Net Kâr Marjı	-80.77%
Borç/Özkaynak Oranı	-499.1%

ARAH uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

ARAH Stoklara Genel Bakış

Risk Analizi

Aleafia Health Inc. Rakipler

XTRA:B8FK

€16.1m

DUSE:SBX

€27.9m

XTRA:HIGH

€57.6m

DB:0RX

€65.0m

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

Red White & Bloom Brands Inc. (CNSX:RWB) completed the acquisition of One Plant (Retail) Corp. and Certain assets of Aleafia Health Inc. for $31.7 million.

Red White & Bloom Brands Inc. (CNSX:RWB) acquired Certain assets of Aleafia Health Inc. for $31.6677 million.

Red White & Bloom Brands Inc. (CNSX:RWB) entered into a stalking horse asset purchase agreement to acquire Certain assets of Aleafia Health Inc.

Aleafia Health Obtains Creditor Protection to Pursue Restructuring and Sale Process

New major risk - Financial position

Full year 2023 earnings released: CA$0.09 loss per share (vs CA$0.42 loss in FY 2022)

Recent updates

Red White & Bloom Brands Inc. (CNSX:RWB) completed the acquisition of One Plant (Retail) Corp. and Certain assets of Aleafia Health Inc. for $31.7 million.

Red White & Bloom Brands Inc. (CNSX:RWB) acquired Certain assets of Aleafia Health Inc. for $31.6677 million.

Red White & Bloom Brands Inc. (CNSX:RWB) entered into a stalking horse asset purchase agreement to acquire Certain assets of Aleafia Health Inc.

Aleafia Health Obtains Creditor Protection to Pursue Restructuring and Sale Process

New major risk - Financial position

Full year 2023 earnings released: CA$0.09 loss per share (vs CA$0.42 loss in FY 2022)

Red White & Bloom Brands Inc. (CNSX:RWB) entered into a binding letter agreement to acquire Aleafia Health Inc. (TSX:AH) from shareholders for CAD 74.98 million.

High number of new and inexperienced directors

Third quarter 2023 earnings released: CA$0.062 loss per share (vs CA$0.22 loss in 3Q 2022)

Aleafia Health Inc. to Report Q3, 2023 Results on Feb 08, 2023

Now 33% undervalued

Aleafia Health Inc. Announces Board Changes

Now 36% undervalued after recent price drop

High number of new and inexperienced directors

High number of new and inexperienced directors

Aleafia Health Inc. to Report Q2, 2023 Results on Nov 09, 2022

Aleafia Health Expands Sunday Market House of Brands with Coveted Lineup of Winter Product Launches

Aleafia Health Announces TSX Decision to Extend Delisting Review Period to November 29, 2022

Aleafia Health Inc. to Report Q2, 2022 Results on Aug 11, 2022

Aleafia Health Inc., Annual General Meeting, Sep 27, 2022

High number of new and inexperienced directors

Full year 2022 earnings released: CA$0.42 loss per share (vs CA$0.84 loss in FY 2021)

Aleafia Health Inc. Reaffirms Revenue Guidance for the Fiscal Year 2023

Aleafia Health Inc. announced that it has received CAD 5.6225 million in funding

High number of new and inexperienced directors

Aleafia Health Inc. announced that it expects to receive CAD 5.6225 million in funding

High number of new and inexperienced directors

Aleafia Health Inc. Reaffirms Earnings Guidance for the Fiscal Year 2022

Aleafia Health Inc. Announces Impairment of Property, Plant & Equipment for the Fourth Quarter Ended December 31, 2021

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Aleafia Health Inc. to Report Q4, 2021 Results on Feb 14, 2022

Aleafia Health Inc. Announces Executive Changes

Third quarter 2021 earnings released: CA$0.25 loss per share (vs CA$0.066 loss in 3Q 2020)

High number of new and inexperienced directors

Aleafia Health Launches Premium Cannabis Brand Nith & Grand

Aleafia Health Expands Bogart’s Kitchen Edibles Portfolio with Launch of Salted Caramel Pretzel Bites

Aleafia Health Inc. Announces It Has Largely Completed Planting Across 86 Acres At Its Outdoor Cultivation Facility in Port Perry, Ont

Aleafia Health Inc. Expands Trailblazing Wellness Brand Noon & Night with Launch of Freshly Minted Roll-On

CFO & Corporate Secretary Benjamin Ferdinand has left the company

Aleafia Health Inc.'s Everyday Cannabis Brand Divvy Launches Large Format Dried Flower Portfolio

First quarter 2021 earnings released: CA$0.036 loss per share (vs CA$0.022 loss in 1Q 2020)

Aleafia Health Inc. Secures Health Canada Research Licence

Full year 2020 earnings released: CA$0.85 loss per share (vs CA$0.18 loss in FY 2019)

Aleafia Health Expands Adult-Use Presence with Entrance in Saskatchewan, New Provincial Market

Aleafia Health Inc. has completed a Composite Units Offering in the amount of CAD 19.92 million.

Aleafia Health Inc. Launches THC Soft Chews Under its Edibles Brand Bogart’s Kitchen

Aleafia Health Inc. to Report Q4, 2020 Results on Mar 25, 2021

Aleafia Health Secures Licence for Toronto Distribution Centre, Expanding Supply Chain and Ecommerce Opportunity

Aleafia Health Inc. Launches Sunday Market House of Brands

New 90-day high: €0.59

Aleafia Health Inc. Announces Directorship Appointments

Aleafia Health Announces Resignation Rhonda Lawson as Director

Unifor and Aleafia Health Enter Exclusive Agreement to Support Medical Cannabis Coverage for Members

Aleafia Health Inc. Enters Definitive Supply Agreement with Apipharm

Unifor and Aleafia Health Inc. Partner on Groundbreaking Medical Cannabis Coverage

New 90-day high: €0.38

Aleafia Health Enters into Supply Agreement with Robes Cannabis Inc

Aleafia Health Launches High Potency CBD 50 Cannabis Oil

Aleafia Health Inc. Launches Kin Slips® Rapid Onset Cannabis-Infused Sublingual Strips

Third quarter 2020 earnings released: CA$0.066 loss per share